Peter J. Choi
Auckland, AUK, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Substituent Effects of Heptamethine Cyanine Dyes on Drug Uptake in Patient-Derived Glioma Cells.
Journal: ChemMedChem
Published: June 08, 2026
Harnessing Targeted Protein Degradation for Developing Brain Cancer Therapy.
Journal: Bioconjugate chemistry
Published: May 04, 2026
mPEG-PLA micelles for nose-to-brain delivery of crizotinib-heptamethine cyanine dye conjugate for potential treatment of glioblastoma.
Journal: Drug delivery and translational research
Published: March 30, 2025
Novel Prodrug Strategies for the Treatment of Tuberculosis.
Journal: Chemistry, an Asian journal
Published: August 04, 2024
Bora-Diaza-Indacene Based Fluorescent Probes for Simultaneous Visualisation of Lipid Droplets and Endoplasmic Reticulum.
Journal: Chembiochem : a European journal of chemical biology
Published: May 10, 2024
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
Journal: Cell communication and signaling : CCS
Published: May 31, 2023
Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue.
Journal: Neuro-oncology advances
Published: November 16, 2022
Synthesis and Structure-Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl-N-(Pyridin-2-ylmethyl)Pyrazolo[1,5-a]Pyrimidin-7-Amines.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 09, 2022
Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.
Journal: Chemical biology & drug design
Published: August 03, 2022
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.
Journal: Molecules (Basel, Switzerland)
Published: November 25, 2021
Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine.
Journal: Tetrahedron letters
Published: October 27, 2021
Last Updated: 09/26/2026